Research Paper Volume 15, Issue 7 pp 2734—2771

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma


Figure 1. The expression analysis of TSEN54 in HCC. (A) Differential expression of TSEN54 in pan-carcinoma and corresponding normal tissues in TIMER. (B) Charts and graphs present the TSEN54 expression in HCC and normal tissues downloaded from the HCCDB database. (C) Plots describe the mRNA expression level of TSEN54 in normal and HCC samples. (D) Paired differential expression of TSEN54 in normal and HCC tissues. The difference representation of TSEN54 in HCC and normal samples was plotted using the (E) GEPIA website and the (F) ICGC database. (G) IHC staining results show the protein expression level of TSEN54 in liver normal tissues and tumor tissues.